Back to top
more

Align Technology (ALGN)

(Delayed Data from NSDQ)

$212.15 USD

212.15
651,165

+1.37 (0.65%)

Updated Nov 5, 2024 04:00 PM ET

After-Market: $211.69 -0.46 (-0.22%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Dental Supplies

Zacks News

McKesson Gains From Distribution Business Amid Pricing Woes

McKesson Corporation's (MCK) Distribution business is driven by market growth and acquisitions. However, pricing remains a concern.

    Haemonetics (HAE) at 52-Week High: What's Driving the Stock?

    Haemonetics (HAE) focuses on development and launch of NexSys PCS plasmapheresis system.

      Varian's Halcyon Receives Shonin Approval, Grows in Oncology

      Varian Medical (VAR) adopts various strategies to boost the Oncology Segment.

        5 Stocks with Recent Price Strength to Boost Your Portfolio

        One should primarily look for stocks that have recently been witnessing price increase. Actually, stocks seeing price strength recently have a high chance of carrying the momentum forward.

          AmerisourceBergen's PharMEDium Slows Down, Competition Rife

          AmerisourceBergen's (ABC) prospects hurt by tepid performance at PharMEDium. Also, steep competition is a cause for concern.

            Align Technology-Glidewell Dental Deal to Boost iTero Uptake

            Align Technology (ALGN) progresses with deals to boost the Scanners and Services segment.

              Intuitive Surgical Hits a 52-Week High on Solid Prospects

              The market is upbeat about Intuitive Surgical's (ISRG) solid procedure performance in Asia, with growth in China, Japan and Korea.

                Wright Medical (WMGI) Rides on Strong Portfolio & Innovation

                Wright Medical (WMGI) is focused on product innovation through research and development. However, lackluster international performance of the lower extremities segment is a matter of concern.

                  Genomic Health Cancer Diagnostic Tests Grow Amid Cost Woes

                  Revenues at Genomic Health (GHDX) improve year over year in Q3, driven by solid performances in the United States and internationally. However, rising operating losses continue to be a spoiler.

                    Medtronic Stock Dips on Preliminary Sales Drag, CRHF to Grow

                    Medtronic's (MDT) latest preliminary sales update for the second quarter of fiscal 2018 holds the market in a bleak light.

                      Ecolab (ECL) to Refinance $375M Worth of Notes, Reduce Debt

                      Ecolab (ECL) plans to reduce debt by refinancing notes with a lower coupon rate.

                        Luminex (LMNX) Banks on FDA Approvals & Portfolio Strength

                        Luminex's (LMNX) collaborative agreements with several companies should help expand the adoption of its products.

                          Intuitive Surgical (ISRG) to Gain From Procedural Business

                          Intuitive Surgical's (ISRG) sales to gain from on da Vinci system and procedural growth in general surgery, oncology, urology and gynecology.

                            LabCorp Reports New Use of Agilent's Cancer Diagnostic Test

                            The testing of the clinical studies needed to approve PD-L1 IHC 28-8 pharmDx assay's new indications were performed at LabCorp's (LH) Center for Molecular Biology and Pathology laboratory.

                              Here's Why Investors Should Buy Myriad Genetics Right Now

                              Myriad Genetics' (MYGN) recent collaborations are encouraging. Also, the company banks on the GeneSight and EndoPredict portfolios.

                                Illumina Introduces NextSeq 550Dx, Updates Use of MiSeqDx

                                Illumina (ILMN) expands NGS platform. The company has a solid diagnostic NGS portfolio, which includes NextSeq 550Dx and MiSeqDx.

                                  Myriad Genetics' Latest Alliance to Boost GeneSight Reach

                                  Myriad Genetics' (MYGN) tie-up with Department of VA to assess the effectiveness of GeneSight test buoys optimism. Also, favorable results might boost GeneSight's customer base

                                    Here's Why Investors Should Buy Luminex (LMNX) Right Now

                                    Luminex (LMNX) continues to grow strong on innovation and product launches.

                                      Haemonetics (HAE) Grows on Strong Plasma, Competition Rife

                                      Despite stiff competition, Haemonetics (HAE) grows on the back of its Plasma and Haemonetics Management franchises.

                                        Align Technology at 52-Week High: What's Driving the Stock?

                                        Align Technology (ALGN) consistently invests in R&D for product innovation.

                                          7 Stocks with Recent Price Strength to Boost Your Portfolio

                                          One should primarily look for stocks that are witnessing price increase. Actually, stocks seeing price strength recently have a high chance of carrying the momentum forward.

                                            Align Technology, Tesla, Apple, Starbucks and Unilever highlighted as Zacks Bull and Bear of the Day

                                            Align Technology, Tesla, Apple, Starbucks and Unilever highlighted as Zacks Bull and Bear of the Day

                                              Becton Dickinson (BDX) in Focus: Stock Moves 7.7% Higher

                                              Becton Dickinson (BDX) saw its shares rise nearly 8% on the day after the company posted better-than-expected third-quarter results.

                                                Kevin Cook headshot

                                                Bull of the Day: Align Technology (ALGN)

                                                This growth story with teeth clearly keeps surprising investors and Wall Street as it delivers another record quarter

                                                  Align Technology (ALGN) Gains on InvisAlign, Competition Rife

                                                  Align Technology (ALGN) continues to gain from strength in the InvisAlign space.